Table 2.
Maternal outcomes of SARS‐CoV‐2 positive and SARS‐CoV‐2 negative pregnant women
| Maternal outcome | SARS‐CoV‐2 positive pregnant women (108) | SARS‐CoV‐2 negative pregnant women (3057) | Estimated effect (95% CI) | p |
|---|---|---|---|---|
| Pregnancy outcomes | ||||
| Term | 71.29 (77) | 84.3 (2578) | 13.01 (5.2–22.2) | p = 0.0003 |
| Preterm | 28.3 (31) | 14.6 (14.6) | 13.7 (5.9–22.9) | p = 0.0001 |
| Mode of delivery | ||||
| LSCS | 63 (58.3%) | 914 (29.8%) | 28.5 (18.9–37.4) | p < 0.0001 |
| Vaginal delivery | 45 (41.6%) | 2143 (70.1%) | 28.5 (18.9–37.4) | p < 0.0001 |
| Maternal ICU admission | 2 (1.85%) | 22 (0.71%) | 1.14 (−0.25 to 5.7) | p = 0.1769 |
| Maternal death | 1 (0.9%) | 7 (0.22%) | 0.68 (−0.1 to 4.7) | p = 0.1586 |
Abbreviations: ICU, intensive care unit; LSCS, lower segment cesarian section.